Roles of tumor suppressors in regulating tumor-associated inflammation (original) (raw)

• Sherr CJ . Principles of tumor suppression. Cell 2004; 116: 235–246.
  Article CAS PubMed Google Scholar
• Hainaut P, Hollstein M . p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 2000; 77: 81–137.
  Article CAS PubMed Google Scholar
• Kruse JP, Gu W . Modes of p53 regulation. Cell 2009; 137: 609–622.
  Article CAS PubMed PubMed Central Google Scholar
• Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994; 107: 369–378.
  Article CAS PubMed Google Scholar
• Yin J, Harpaz N, Tong Y, Huang Y, Laurin J, Greenwald BD et al. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 1993; 104: 1633–1639.
  Article CAS PubMed Google Scholar
• Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 2000; 60: 3333–3337.
  CAS PubMed Google Scholar
• Linderholm B, Lindh B, Tavelin B, Grankvist K, Henriksson R . p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer 2000; 89: 51–62.
  Article CAS PubMed Google Scholar
• Monnier Y, Zaric J, Ruegg C . Inhibition of angiogenesis by non-steroidal anti-inflammatory drugs: from the bench to the bedside and back. Curr Drug Targets Inflamm Allergy 2005; 4: 31–38.
  Article CAS PubMed Google Scholar
• Salvado MD, Alfranca A, Haeggstrom JZ, Redondo JM . Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2. TrendsMol Med 2012; 18: 233–243.
  Article CAS Google Scholar
• Lee TL, Yang XP, Yan B, Friedman J, Duggal P, Bagain L et al. A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status. Clin Cancer Res 2007; 13: 5680–5691.
  Article CAS PubMed Google Scholar
• Farazi PA, Zeisberg M, Glickman J, Zhang Y, Kalluri R, DePinho RA . Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice. Cancer Res 2006; 66: 6622–6627.
  Article CAS PubMed Google Scholar
• Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S et al. Mutant p53 prolongs nf-kappab activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell 2013; 23: 634–646.
  Article CAS PubMed PubMed Central Google Scholar
• Shaked H, Hofseth LJ, Chumanevich A, Chumanevich AA, Wang J, Wang Y et al. Chronic epithelial NF-kappaB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation. Proc Natl Acad Sci USA 2012; 109: 14007–14012.
  Article CAS PubMed PubMed Central Google Scholar
• Hussain SP, He P, Subleski J, Hofseth LJ, Trivers GE, Mechanic L et al. Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res 2008; 68: 7130–7136.
  Article CAS PubMed PubMed Central Google Scholar
• Komarova EA, Krivokrysenko V, Wang K, Neznanov N, Chernov MV, Komarov PG et al. p53 is a suppressor of inflammatory response in mice. FASEB J 2005; 19: 1030–1032.
  Article CAS PubMed Google Scholar
• Ruzankina Y, Schoppy DW, Asare A, Clark CE, Vonderheide RH, Brown EJ . Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53. Nat Genet 2009; 41: 1144–1149.
  Article CAS PubMed PubMed Central Google Scholar
• Schwitalla S, Ziegler PK, Horst D, Becker V, Kerle I, Begus-Nahrmann Y et al. Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell 2013; 23: 93–106.
  Article CAS PubMed Google Scholar
• Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE et al. Non-cell-autonomous tumor suppression by p53. Cell 2013; 153: 449–460.
  Article CAS PubMed PubMed Central Google Scholar
• Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445: 656–660.
  Article CAS PubMed PubMed Central Google Scholar
• Vousden KH, Prives C . Blinded by the light: the growing complexity of p53. Cell 2009; 137: 413–431.
  Article CAS PubMed Google Scholar
• Brosh R, Rotter V . When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 2009; 9: 701–713.
  Article CAS PubMed Google Scholar
• Lu H, Yang X, Duggal P, Allen CT, Yan B, Cohen J _et al_2011 TNF-alpha promotes c-REL/DeltaNp63alpha interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer. Cancer Res 71: 6867–6877.
  Article CAS PubMed PubMed Central Google Scholar
• Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 2008; 22: 2677–2691.
  Article CAS PubMed PubMed Central Google Scholar
• Yang X, Lu H, Yan B, Romano RA, Bian Y, Friedman J et al. DeltaNp63 versatilely regulates a broad NF-kappaB gene program and promotes squamous epithelial proliferation, migration, and inflammation. Cancer Res 2011; 71: 3688–3700.
  Article CAS PubMed PubMed Central Google Scholar
• Bieging KT, Mello SS, Attardi LD . Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 2014; 14: 359–370.
  Article CAS PubMed PubMed Central Google Scholar
• Grivennikov SI, Greten FR, Karin M . Immunity, inflammation, and cancer. Cell 2010; 140: 883–899.
  Article CAS PubMed PubMed Central Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F . Cancer-related inflammation. Nature 2008; 454: 436–444.
  Article CAS PubMed Google Scholar
• Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960–1964.
  Article CAS PubMed Google Scholar
• Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011; 71: 1263–1271.
  Article CAS PubMed Google Scholar
• Amos-Landgraf JM, Irving AA, Hartman C, Hunter A, Laube B, Chen X et al. Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms. Proc Natl Acad Sci USA 2012; 109: 2060–2065.
  Article CAS PubMed PubMed Central Google Scholar
• Bilger A, Shoemaker AR, Gould KA, Dove WF . Manipulation of the mouse germline in the study of Min-induced neoplasia. Semin Cancer Biol 1996; 7: 249–260.
  Article CAS PubMed Google Scholar
• Merritt AJ, Gould KA, Dove WF . Polyclonal structure of intestinal adenomas in ApcMin/+ mice with concomitant loss of Apc+ from all tumor lineages. Proc Natl Acad Sci USA 1997; 94: 13927–13931.
  Article CAS PubMed PubMed Central Google Scholar
• Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012; 491: 254–258.
  Article CAS PubMed PubMed Central Google Scholar
• Chia WK, Ali R, Toh HC . Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms. Nat Rev Clin Oncol 2012; 9: 561–570.
  Article CAS PubMed Google Scholar
• Song MS, Salmena L, Pandolfi PP . The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 2012; 13: 283–296.
  Article CAS PubMed Google Scholar
• Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998; 95: 29–39.
  Article CAS PubMed Google Scholar
• Bian Y, Hall B, Sun ZJ, Molinolo A, Chen W, Gutkind JS et al. Loss of TGF-beta signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene 2012; 31: 3322–3332.
  Article CAS PubMed Google Scholar
• Ying H, Elpek KG, Vinjamoori A, Zimmerman SM, Chu GC, Yan H et al. PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-kappaB-cytokine network. Cancer discovery 2011; 1: 158–169.
  Article CAS PubMed PubMed Central Google Scholar
• Wallace JA, Li F, Leone G, Ostrowski MC . Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution. Cancer Res 2011; 71: 1203–1207.
  Article CAS PubMed PubMed Central Google Scholar
• Hanahan D, W RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.
  Article CAS PubMed Google Scholar
• Balkwill F, Coussens LM . Cancer: an inflammatory link. Nature 2004; 431: 405–406.
  Article CAS PubMed Google Scholar
• Coussens LM, Werb Z . Inflammation and cancer. Nature 2002; 420: 860–867.
  Article CAS PubMed PubMed Central Google Scholar
• Bristow RG, Hill RP . Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 2008; 8: 180–192.
  Article CAS PubMed Google Scholar
• Kalluri R, Zeisberg M . Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392–401.
  Article CAS PubMed Google Scholar
• Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335–348.
  Article CAS PubMed Google Scholar
• Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008; 14: 518–527.
  Article CAS PubMed Google Scholar
• Dierks C, Grbic J, Zirlik K, Beigi R, Englund NP, Guo GR et al. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med 2007; 13: 944–951.
  Article CAS PubMed Google Scholar
• Zhang W, Kater AP, Widhopf GF 2nd, Chuang HY, Enzler T, James DF et al. B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2010; 107: 18956–18960.
  Article CAS PubMed PubMed Central Google Scholar
• Weinberg RA . Coevolution in the tumor microenvironment. Nat Genet 2008; 40: 494–495.
  Article CAS PubMed Google Scholar
• Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C . Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 2002; 32: 355–357.
  Article CAS PubMed Google Scholar
• Patocs A, Zhang L, Xu Y, Weber F, Caldes T, Mutter GL et al. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 2007; 357: 2543–2551.
  Article CAS PubMed Google Scholar
• Campbell IG, Qiu W, Polyak K, Haviv I . Breast-cancer stromal cells with TP53 mutations. N Engl J Med 2008 author reply 358: 1634–1635.
  Article CAS PubMed Google Scholar
• Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M et al. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 2008; 40: 650–655.
  Article CAS PubMed PubMed Central Google Scholar
• Hill R, Song Y, Cardiff RD, Van Dyke T . Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 2005; 123: 1001–1011.
  Article CAS PubMed Google Scholar
• Svensson RU, Haverkamp JM, Thedens DR, Cohen MB, Ratliff TL, Henry MD . Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer. Am J Pathol 2011; 179: 502–512.
  Article PubMed PubMed Central Google Scholar
• Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009; 461: 1084–1091.
  Article CAS PubMed PubMed Central Google Scholar
• Bronisz A, Godlewski J, Wallace JA, Merchant AS, Nowicki MO, Mathsyaraja H et al. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol 2012; 14: 159–167.
  Article CAS Google Scholar
• Achyut BR, Bader DA, Robles AI, Wangsa D, Harris CC, Ried T et al. Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-beta signaling. PLoS Genet 2013; 9: e1003251.
  Article CAS PubMed PubMed Central Google Scholar
• Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303: 848–851.
  Article CAS PubMed Google Scholar
• Park KS, Martelotto LG, Peifer M, Sos ML, Karnezis AN, Mahjoub MR et al. A crucial requirement for Hedgehog signaling in small cell lung cancer. Nat Med 2011; 17: 1504–1508.
  Article CAS PubMed PubMed Central Google Scholar
• Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M . B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 2010; 464: 302–305.
  Article CAS PubMed PubMed Central Google Scholar
• Ben-Neriah Y, Karin M . Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 2011; 12: 715–723.
  Article CAS PubMed Google Scholar
• Karin M, Greten FR . NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5: 749–759.
  Article CAS PubMed Google Scholar
• Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285–296.
  Article CAS PubMed Google Scholar
• Meylan E, Dooley AL, Feldser DM, Shen L, Turk E, Ouyang C et al. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 2009; 462: 104–107.
  Article CAS PubMed PubMed Central Google Scholar
• Perkins ND . Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007; 8: 49–62.
  Article CAS PubMed Google Scholar
• Murphy SH, Suzuki K, Downes M, Welch GL, De Jesus P, Miraglia LJ et al. Tumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptor. Proc Natl Acad Sci USA 2011; 108: 17117–17122.
  Article CAS PubMed PubMed Central Google Scholar
• Wang J, An H, Mayo MW, Baldwin AS, Yarbrough WG . LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. Cancer Cell 2007; 12: 239–251.
  Article CAS PubMed Google Scholar
• Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL et al. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 2007; 446: 690–694.
  Article CAS PubMed Google Scholar
• Tan W, Zhang W, Strasner A, Grivennikov S, Cheng JQ, Hoffman RM et al. Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature 2011; 470: 548–553.
  Article CAS PubMed PubMed Central Google Scholar
• Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G . The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 2003; 424: 801–805.
  Article CAS PubMed Google Scholar
• Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 2000; 25: 160–165.
  Article CAS PubMed Google Scholar
• Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fassler R . Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell 2006; 125: 665–677.
  Article CAS PubMed Google Scholar
• Nikolaou K, Tsagaratou A, Eftychi C, Kollias G, Mosialos G, Talianidis I . Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer. Cancer Cell 2012; 21: 738–750.
  Article CAS PubMed Google Scholar
• Bard-Chapeau EA, Li S, Ding J, Zhang SS, Zhu HH, Princen F et al. Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell 2011; 19: 629–639.
  Article CAS PubMed PubMed Central Google Scholar
• Fukuda A, Wang SC, JPt Morris, Folias AE, Liou A, Kim GE et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 2011; 19: 441–455.
  Article CAS PubMed PubMed Central Google Scholar
• Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G et al. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 2006; 126: 489–502.
  Article CAS PubMed Google Scholar
• Lesina M, Kurkowski MU, Ludes K, Rose-John S, Treiber M, Kloppel G et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 2011; 19: 456–469.
  Article CAS PubMed Google Scholar
• Liang J, Nagahashi M, Kim EY, Harikumar KB, Yamada A, Huang WC et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell 2013; 23: 107–120.
  Article CAS PubMed Google Scholar
• He G, Yu GY, Temkin V, Ogata H, Kuntzen C, Sakurai T et al. Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell 2010; 17: 286–297.
  Article CAS PubMed PubMed Central Google Scholar
• Li Y, de Haar C, Peppelenbosch MP, van der Woude CJ . SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer. Cytokine Growth Factor Rev 2012; 23: 127–138.
  Article CAS PubMed Google Scholar
• Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, Stanley EG et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 2003; 4: 540–545.
  Article CAS PubMed Google Scholar
• Ogata H, Chinen T, Yoshida T, Kinjyo I, Takaesu G, Shiraishi H et al. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene 2006; 25: 2520–2530.
  Article CAS PubMed Google Scholar
• Tang Y, Kitisin K, Jogunoori W, Li C, Deng CX, Mueller SC et al. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc Natl Acad Sci USA 2008; 105: 2445–2450.
  Article CAS PubMed PubMed Central Google Scholar
• Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M et al. Abrogation of TGFbeta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008; 13: 23–35.
  Article CAS PubMed PubMed Central Google Scholar
• Yang L . TGFbeta and cancer metastasis: an inflammation link. Cancer Metastasis Rev 2010; 29: 263–271.
  Article PubMed CAS PubMed Central Google Scholar
• Kitamura T, Kometani K, Hashida H, Matsunaga A, Miyoshi H, Hosogi H et al. SMAD4-deficient intestinal tumors recruit CCR1(+) myeloid cells that promote invasion. Nat Genet 2007; 39: 467–475.
  Article CAS PubMed Google Scholar
• Kim BG, Li C, Qiao W, Mamura M, Kasprzak B, Anver M et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 2006; 441: 1015–1019.
  Article CAS PubMed Google Scholar
• Donkor MK, Sarkar A, Savage PA, Franklin RA, Johnson LK, Jungbluth AA et al. T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-beta1 cytokine. Immunity 2011; 35: 123–134.
  Article CAS PubMed PubMed Central Google Scholar
• Singh S, Singh R, Sharma PK, Singh UP, Rai SN, Chung LW et al. Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Cancer Lett 2009; 283: 29–35.
  Article CAS PubMed PubMed Central Google Scholar
• Hiratsuka S, Watanabe A, Aburatani H, Maru Y . Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 2006; 8: 1369–1375.
  Article CAS PubMed Google Scholar
• Monteleone G, Mann J, Monteleone I, Vavassori P, Bremner R, Fantini M et al. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation. J Biol Chem 2004; 279: 3925–3932.
  Article CAS PubMed Google Scholar
• Hong S, Lee C, Kim SJ . Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway. Cancer Res 2007; 67: 9577–9583.
  Article CAS PubMed Google Scholar
• Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM . Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res 2006; 66: 828–838.
  Article CAS PubMed PubMed Central Google Scholar
• Engle SJ, Ormsby I, Pawlowski S, Boivin GP, Croft J, Balish E et al. Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res 2002; 62: 6362–6366.
  CAS PubMed Google Scholar
• Lu T, Tian L, Han Y, Vogelbaum M, Stark GR . Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways. Proc Natl Acad Sci USA 2007; 104: 4365–4370.
  Article CAS PubMed PubMed Central Google Scholar
• Lu SL, Reh D, Li AG, Woods J, Corless CL, Kulesz-Martin M et al. Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res 2004; 64: 4405–4410.
  Article CAS PubMed Google Scholar
• Bierie B, Chung CH, Parker JS, Stover DG, Cheng N, Chytil A et al. Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. J Clin Invest 2009; 119: 1571–1582.
  Article CAS PubMed PubMed Central Google Scholar
• Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008; 13: 206–220.
  Article CAS PubMed PubMed Central Google Scholar
• Pang Y, Gara SK, Achyut BR, Li Z, Yan HH, Day CP et al. Transforming growth factor beta signaling in myeloid cells is required for tumor metastasis. Cancer discovery 2013; 3: 936–951.
  Article CAS PubMed PubMed Central Google Scholar
• Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004; 303: 844–848.
  Article CAS PubMed Google Scholar
• Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 2013; 19: 1264–1272.
  Article CAS PubMed PubMed Central Google Scholar
• Qian BZ, Pollard JW . Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141: 39–51.
  Article CAS PubMed PubMed Central Google Scholar
• Gabrilovich DI, Nagaraj S . Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162–174.
  Article CAS PubMed PubMed Central Google Scholar
• Ferris RL, Grandis JR . NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma. Clin Cancer Res 2007; 13: 5663–5664.
  Article CAS PubMed Google Scholar
• Scian MJ, Stagliano KE, Anderson MA, Hassan S, Bowman M, Miles MF et al. Tumor-derived p53 mutants induce NF-kappaB2 gene expression. Mol Cell Biol 2005; 25: 10097–10110.
  Article CAS PubMed PubMed Central Google Scholar
• Chlebowski RT, McTiernan A, Wactawski-Wende J, Manson JE, Aragaki AK, Rohan T et al. Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol 2012; 30: 2844–2852.
  Article PubMed PubMed Central Google Scholar
• Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW . Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011; 377: 31–41.
  Article CAS PubMed Google Scholar
• Farazi PA, Zeisberg M, Glickman J, Zhang Y, Kalluri R, DePinho RA . Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice. Cancer Res 2006; 66: 6622–6627.
  Article CAS PubMed Google Scholar
• Schwitalla S, Ziegler PK, Horst D, Becker V, Kerle I, Begus-Nahrmann Y et al. Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell 2013; 23: 93–106.
  Article CAS PubMed Google Scholar
• Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE et al. Non-cell-autonomous tumor suppression by p53. Cell 2013; 153: 449–460.
  Article CAS PubMed PubMed Central Google Scholar
• Hill R, Song Y, Cardiff RD, Van Dyke T . Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 2005; 123: 1001–1011.
  Article CAS PubMed Google Scholar
• Chien WM, Garrison K, Caufield E, Orthel J, Dill J, Fero ML . Differential gene expression of p27Kip1 and Rb knockout pituitary tumors associated with altered growth and angiogenesis. Cell Cycle 2007; 6: 750–757.
  Article CAS PubMed Google Scholar
• Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012; 491: 254–258.
  Article CAS PubMed PubMed Central Google Scholar
• Ying H, Elpek KG, Vinjamoori A, Zimmerman SM, Chu GC, Yan H et al. PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-kappaB-cytokine network. Cancer Discov 2011; 1: 158–169.
  Article CAS PubMed PubMed Central Google Scholar
• Bian Y, Hall B, Sun ZJ, Molinolo A, Chen W, Gutkind JS et al. Loss of TGF-beta signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene 2012; 31: 3322–3332.
  Article CAS PubMed Google Scholar
• Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009; 461: 1084–1091.
  Article CAS PubMed PubMed Central Google Scholar
• Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M et al. Abrogation of TGFbeta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008; 13: 23–35.
  Article CAS PubMed PubMed Central Google Scholar
• Yang L . TGFbeta and cancer metastasis: an inflammation link. Cancer Metastasis Rev 2010; 29: 263–271.
  Article PubMed CAS PubMed Central Google Scholar
• Achyut BR, Bader DA, Robles AI, Wangsa D, Harris CC, Ried T et al. Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-beta signaling. PLoS Genet 2013; 9: e1003251.
  Article CAS PubMed PubMed Central Google Scholar
• Kitamura T, Kometani K, Hashida H, Matsunaga A, Miyoshi H, Hosogi H et al. SMAD4-deficient intestinal tumors recruit CCR1(+) myeloid cells that promote invasion. Nat Genet 2007; 39: 467–475.
  Article CAS PubMed Google Scholar
• Kim BG, Li C, Qiao W, Mamura M, Kasprzak B, Anver M et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 2006; 441: 1015–1019.
  Article CAS PubMed Google Scholar